Company Comparator
Side-by-side analysis of supply chain position, institutional signals, and news gap scores.
Market Cap Tier
Chain Role
Gap Score
IB Activity
Revenue Mix Comparison
About
Eli Lilly is the world's most valuable pharmaceutical company, propelled by the blockbuster GLP-1 receptor agonist tirzepatide (Mounjaro/Zepbound) for diabetes and obesity. Its Alzheimer's antibody donanemab and strong oncology pipeline give it one of the most promising drug portfolios in the industry.
Founded
1876
Employees
43,000+
Headquarters
Indianapolis, Indiana, USA
Revenue
$52.8B
News Gap Signal
No news gap data tracked for this ticker.
Institutional Signals
No 13F signals on record for this ticker.
Cascade Patterns
Key Relationships
About
Novo Nordisk is the global leader in diabetes care and has become a GLP-1 giant with Ozempic and Wegovy. The obesity-drug revolution has made it Europe's most valuable company. Its near-monopoly on injectable semaglutide positions it at the center of the $100B+ weight-loss drug market.
Founded
1923
Employees
64,000+
Headquarters
Bagsvaerd, Denmark
Revenue
$42.6B
News Gap Signal
No news gap data tracked for this ticker.
Institutional Signals
No 13F signals on record for this ticker.